Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 20, 2024 - Issue 1
Submit an article Journal homepage
503
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Ethical concerns regarding heterologous COVID-19 vaccine administration

Somsri Wiwanitkita Private Academic and Editorial Consultant, Bangkok, ThailandCorrespondence[email protected]
&
Viroj Wiwanitkitb Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences Saveetha University IndiaORCID Iconhttps://orcid.org/0000-0003-1039-3728
ORCID Icon
Article: 2313250 | Published online: 14 Feb 2024

References

  • Kyaw MH, Spinardi J, Zhang L, Oh HML, Srivastava A. Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Hum Vaccin Immunother. 2023 Dec 31;19(1):2165856. doi:10.1080/21645515.2023.2165856.
  • Yasri S, Wiwanitkit V. Heterologous mRNA-based COVID-19 booster strategies: comment. Hum Vaccin Immunother. 2023 Dec 31;19(1):2174758. doi:10.1080/21645515.2023.2174758.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.